FindTrial
Sign In

Management of glycemic variations in diabetic patients receiving parenteral nutrition outside intensive care units by continuous subcutaneous insulin infusion (CSII) therapy

Management of glycemic variations in diabetic patients receiving parenteral nutrition outside intensive care units by continuous subcutaneous insulin infusion (CSII) therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011261
Enrollment
Unknown
Registered
2017-04-28
Start date
2017-04-27
Completion date
Unknown
Last updated
2017-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

CSII group:CSII therapy
MDI group:MDI therapy

Sponsors

Nanjing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients aged between 18 and 80 years; 2. Confirmed type 2 diabetes with history or HbA1c above 6.5%; 3. Body mass index: 21 to 35 kg/m2.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had a blood glucose concentration >200 mg/ dL, chronic kidney disease, or were unwilling to participate.

Design outcomes

Primary

MeasureTime frame
MAGE;24-hr MG;SDBG;—

Countries

China

Contacts

Public ContactJianhua Ma

Nanjing First Hospital

majianhua196503@126.com+86 18951670116

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026